Back

MANTA vascular closure device bleeding and vascular complications in association with cardiovascular risk factors: a large single centre experience

28 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Vascular access, robotics, and diagnostics Vascular Access ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mohamed Ramzi Almajed

Henry Ford Hospital, Detroit (United States of America)

7 More presentations in this session

Presentation thumbnail
Transulnar artery approach in STEMI - Best alternative to radial?
Associate Professor B. Zafirovska Taleska (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
Incidence and determinants of non-radial vascular approach for coronary angiography among heart transplant recipients
Doctor N. Procopi (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Preliminary results of the feasibility and precision of optical coherence tomography guided and robotic-assisted PCI (Robo-OCT) study
Doctor J. Rilinger (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Predictors of residual lipid content detected by near-infrared spectroscopy after elective stenting in patients with chronic coronary syndrome
Doctor M. Hada (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Appropriate ischemic criteria for type 4a myocardial infarction: insights from the ALPHEUS trial
Professor J. Silvain (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Vascular access, robotics, and diagnostics

The Event

Event poster

ESC Congress 2023

28 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Vascular closure after TAVI: assessing the safety and efficacy of a collagen-based device in a real-world population
thumbnail
Congress Presentation
Vascular complications following TAVI: safety and predictors of the MANTA vascular closure device
thumbnail
Congress Presentation
Bleeding risk stratification in patients undergoing transcatheter aortic valve replacement: enhancing VARC-HBR criteria with CT-ADP as a marker of primary hemostatic disorder

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources